Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
25 hedge funds and large institutions have $5.49M invested in Vaccinex, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
231% more capital invested
Capital invested by funds: $1.66M → $5.49M (+$3.83M)
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
19% more funds holding
Funds holding: 21 → 25 (+4)
50% less call options, than puts
Call options by funds: $53K | Put options by funds: $105K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.74M |
| 2 |
TI
Telemetry Investments
New York
|
+$536K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$143K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$87.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$222K |
| 2 |
N
Natixis
Paris,
France
|
-$33K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$7.46K |
| 5 |
BlackRock
New York
|
-$3.04K |
VCNX Hedge Fund Activity: Q1 2022 in Review
25 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2022, worth a combined $5.49M — up 231% from $1.66M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VCNX positions and 4 closed out — a net gain of 4 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $2.74M. The largest seller was Point72 Asset Management, cutting an estimated $222K.
- 25 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2022, up from 21 in Q4 2021.
- Funds reported $5.49M of Vaccinex, Inc. Common Stock stock for Q1 2022, up 231% quarter-over-quarter.
- 8 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2022 and 4 closed out, a net change of +4 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q1 2022 was AIGH Capital Management, an estimated $2.74M added.
- The largest Vaccinex, Inc. Common Stock seller in Q1 2022 was Point72 Asset Management, an estimated $222K sold.
Based on aggregated 13F filings for Q1 2022.